Here, we demonstrate that UBR5 is required for IFN-γ-induced PD-L1 expression in breast cancer, and that transactivation of PDL1 gene expression by UBR5 is mediated through the PKR/STAT1/IRF1 pathway. The gene discussed is EIF2AK2; the disease is breast cancer.